Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms.
A benign deficiency (pseudodeficiency) of the lysosomal enzyme arylsulphatase A (ASA) (EC 3.1.6.8) towards synthetic substrates complicates the diagnosis of metachromatic leukodystrophy (MLD). The pseudodeficiency is due to a single base substitution in the 3'-untranslated region of the ASA gene (1524+95 A-->G) and it has been reported that this mutation (PD2) always occurs on a chromosome carrying a second mutation in the ASA gene (PD1), which abolishes an N-glycosylation site (N350S). Analysis of the two PD mutations in the ASA gene separately was carried out in a large group of subjects with neurological symptoms and low ASA activity, including close relatives and MLD patients. The relationship between ASA enzyme activity and the different genotypes identified is presented. Evidence for the existence of an allele containing the PD2 mutation alone is presented. A strategy for cases with low ASA activity and neurological symptoms in families carrying a PD allele or both PD and MLD alleles is proposed.
Leistner
S
S
Division of Biochemistry and Genetics, Institute of Child Health, London, UK.
Young
E
E
Meaney
C
C
Winchester
B
B
D002553:Cerebroside-Sulfatase / Q000172:deficiency* / Q000235:genetics; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D007966:Leukodystrophy, Metachromatic / Q000235:genetics*; D009154:Mutation
D002553:Cerebroside-Sulfatase